KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Ingredients (ALTO) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Alto Ingredients (ALTO) over the last 15 years, with Q3 2025 value amounting to -$1.6 million.

  • Alto Ingredients' Cash from Investing Activities fell 169450.55% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.4 million, marking a year-over-year increase of 2141.1%. This contributed to the annual value of -$13.5 million for FY2024, which is 5923.22% up from last year.
  • As of Q3 2025, Alto Ingredients' Cash from Investing Activities stood at -$1.6 million, which was down 169450.55% from -$2.7 million recorded in Q2 2025.
  • In the past 5 years, Alto Ingredients' Cash from Investing Activities ranged from a high of $19.9 million in Q4 2021 and a low of -$17.0 million during Q1 2022
  • Moreover, its 5-year median value for Cash from Investing Activities was -$6.0 million (2024), whereas its average is -$3.6 million.
  • In the last 5 years, Alto Ingredients' Cash from Investing Activities surged by 13969.1% in 2021 and then plummeted by 169450.55% in 2025.
  • Alto Ingredients' Cash from Investing Activities (Quarter) stood at $19.9 million in 2021, then tumbled by 163.01% to -$12.5 million in 2022, then skyrocketed by 60.67% to -$4.9 million in 2023, then soared by 74.02% to -$1.3 million in 2024, then dropped by 27.78% to -$1.6 million in 2025.
  • Its Cash from Investing Activities was -$1.6 million in Q3 2025, compared to -$2.7 million in Q2 2025 and -$7.8 million in Q1 2025.